{"id":31449,"date":"2023-03-16T17:45:00","date_gmt":"2023-03-16T16:45:00","guid":{"rendered":"https:\/\/www.transgene.com\/?p=31449"},"modified":"2026-07-09T15:11:45","modified_gmt":"2026-07-09T13:11:45","slug":"les-donnees-positives-generees-en-2022-avec-les-principaux-candidats-cliniques-confortent-les-perspectives-de-transgene-pour-2023-dans-un-contexte-porteur-pour-les-vaccins-therapeutiques-contre-le-ca","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/les-donnees-positives-generees-en-2022-avec-les-principaux-candidats-cliniques-confortent-les-perspectives-de-transgene-pour-2023-dans-un-contexte-porteur-pour-les-vaccins-therapeutiques-contre-le-ca\/","title":{"rendered":"Les donn\u00e9es positives g\u00e9n\u00e9r\u00e9es en 2022 avec les principaux candidats cliniques confortent les perspectives de Transgene pour 2023, dans un contexte porteur pour les vaccins th\u00e9rapeutiques contre le cancer et les virus oncolytiques"},"content":{"rendered":"\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n\n\n\n<p class=\"eplus-DVrMbh\"><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20230316_Transgene_2022_Full-Year_Results_FR.pdf\">Resultats annuels 2022 et point sur l&rsquo;activit\u00e9<\/a><\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp; Resultats annuels 2022 et point sur l&rsquo;activit\u00e9<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[164,11,128],"tags":[],"class_list":["post-31449","post","type-post","status-publish","format-standard","hentry","category-164","category-press-release-fr","category-dates","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"nh","author_link":"https:\/\/www.transgene.com\/fr\/author\/nh\/"},"uagb_comment_info":0,"uagb_excerpt":"&nbsp; &nbsp; Resultats annuels 2022 et point sur l&rsquo;activit\u00e9","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=31449"}],"version-history":[{"count":1,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31449\/revisions"}],"predecessor-version":[{"id":41529,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31449\/revisions\/41529"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=31449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=31449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=31449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}